These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 16613739)
1. Kinetics and activity of arylsulfatase A in leukocytes derived from patients with cerebral palsy. Bognar SK; Foretić B; Furac I; Vukelić Z; Grubesić Z Acta Pharm; 2006 Mar; 56(1):95-104. PubMed ID: 16613739 [TBL] [Abstract][Full Text] [Related]
2. Croatian population data for arylsulfatase a pseudodeficiency-associated mutations in healthy subjects, and in patients with Alzheimer-type dementia and Down syndrome. Bognar SK; Furac I; Kubat M; Cosović C; Demarin V Arch Med Res; 2002; 33(5):473-7. PubMed ID: 12459318 [TBL] [Abstract][Full Text] [Related]
3. Diffuse-disseminated sclerosis combined with partial arylsulfatase A (ASA) deficiency. Mixed heterozygosity of ASA- and pseudo-ASA-deficiency? Peiffer J; Harzer K; Schlote W Neuropediatrics; 1984 May; 15(2):59-62. PubMed ID: 6146104 [TBL] [Abstract][Full Text] [Related]
4. Leukocyte arylsulfatase A activity in patients with alcohol-related cirrhosis. Alvarez-Leal M; Contreras-Hernández D; Chávez A; Diaz-Contreras JA; Careaga-Olivares J; Zúñiga-Charles MA; Reynoso MC; Hernández-Téllez A Am J Hum Biol; 2001; 13(3):297-300. PubMed ID: 11460894 [TBL] [Abstract][Full Text] [Related]
5. Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy. Berger J; Löschl B; Bernheimer H; Lugowska A; Tylki-Szymanska A; Gieselmann V; Molzer B Am J Med Genet; 1997 Mar; 69(3):335-40. PubMed ID: 9096767 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of partial cerebroside sulfate sulfatase (arylsulfatase A) defect in adult psychiatric patients. Shah SN; Johnson RC; Stone RK; Mahon-Haft H Biol Psychiatry; 1985 Jan; 20(1):50-7. PubMed ID: 2856894 [TBL] [Abstract][Full Text] [Related]
8. Mutations c.459+1G>A and p.P426L in the ARSA gene: prevalence in metachromatic leukodystrophy patients from European countries. Lugowska A; Amaral O; Berger J; Berna L; Bosshard NU; Chabas A; Fensom A; Gieselmann V; Gorovenko NG; Lissens W; Mansson JE; Marcao A; Michelakakis H; Bernheimer H; Ol'khovych NV; Regis S; Sinke R; Tylki-Szymanska A; Czartoryska B Mol Genet Metab; 2005 Nov; 86(3):353-9. PubMed ID: 16140556 [TBL] [Abstract][Full Text] [Related]
9. Contribution of arylsulfatase A mutations located on the same allele to enzyme activity reduction and metachromatic leukodystrophy severity. Regis S; Corsolini F; Stroppiano M; Cusano R; Filocamo M Hum Genet; 2002 Apr; 110(4):351-5. PubMed ID: 11941485 [TBL] [Abstract][Full Text] [Related]
10. Detection of arylsulfatase A in leukocytes and urines of late infantile metachromatic leukodystrophy. Report of 3 cases. Wang DF; Zhao KW; Zeng JS; Li LQ; Sun YX; Gao QZ Chin Med J (Engl); 1988 Nov; 101(11):793-7. PubMed ID: 2907984 [No Abstract] [Full Text] [Related]
11. [Activity of aryl sulfatase A enzyme in patients with schizophrenic disorders]. Alvarez Leal M; Castillo Solís T; Pérez Zuno JA; Vargas Ramos I; Sepúlveda García R; Zúñiga Charles MA Rev Invest Clin; 1995; 47(5):387-92. PubMed ID: 8584809 [TBL] [Abstract][Full Text] [Related]
12. Leukocyte sulfatidase for the reliable diagnosis of metachromatic leukodystrophy. Raghavan SS; Gajewski A; Kolodny EH J Neurochem; 1981 Feb; 36(2):724-31. PubMed ID: 6109767 [TBL] [Abstract][Full Text] [Related]
13. Reduced activity of arylsulfatase A and predisposition to neurological disorders: analysis of 140 pediatric patients. Sangiorgi S; Ferlini A; Zanetti A; Mochi M Am J Med Genet; 1991 Sep; 40(3):365-9. PubMed ID: 1683156 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of pyrene derivatives of cerebroside sulfate and their use for determining arylsulfatase A activity. Marchesini S; Viani P; Cestaro B; Gatt S Biochim Biophys Acta; 1989 Mar; 1002(1):14-9. PubMed ID: 2564282 [TBL] [Abstract][Full Text] [Related]
15. Adult metachromatic leukodystrophy: a new mutation in the schizophrenia-like phenotype with early neurological signs. Kumperscak HG; Plesnicar BK; Zalar B; Gradisnik P; Seruga T; Paschke E Psychiatr Genet; 2007 Apr; 17(2):85-91. PubMed ID: 17413447 [TBL] [Abstract][Full Text] [Related]
16. [Molecular screening of the major mutations in the ARSA gene in patients with metachromatic leukodystrophy]. Horovenko NH; Ol'khovych NV; Pichkur NO Tsitol Genet; 2002; 36(5):43-8. PubMed ID: 12442547 [TBL] [Abstract][Full Text] [Related]
17. Arylsulfatase A pseudodeficiency incidence in Turkey. Emre S; Topçu M; Terzioğlu M; Renda Y Turk J Pediatr; 2000; 42(2):115-7. PubMed ID: 10936976 [TBL] [Abstract][Full Text] [Related]
18. Molecular and clinical consequences of novel mutations in the arylsulfatase A gene. Ługowska A; Wlodarski P; Płoski R; Mierzewska H; Dudzińska M; Matheisel A; Swietochowska H; Tylki-Szymańska A Clin Genet; 2009 Jan; 75(1):57-64. PubMed ID: 19021637 [TBL] [Abstract][Full Text] [Related]
19. Novel mutations in the arylsulfatase A gene in eight Italian families with metachromatic leukodystrophy. Bertelli M; Gallo S; Buda A; Cecchin S; Fabbri A; Lapucci C; Andrighetto G; Sidoti V; Lorusso L; Pandolfo M J Clin Neurosci; 2006 May; 13(4):443-8. PubMed ID: 16678723 [TBL] [Abstract][Full Text] [Related]
20. Arylsulfatase A pseudodeficiency: altered kinetic and heat-inactivation properties. Qu Y; Miller JB; Desnick RJ; Shapira E Genet Test; 1997-1998; 1(4):283-7. PubMed ID: 10464659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]